Spotlight session: How CDMOs can drive innovation in CGT manufacturing

CDMOs play a pivotal role in enabling biotechs and pharma to bring CGT products to market efficiently. This session examines how CDMOs can implement innovative manufacturing approaches, optimize workflows, and support scalable production while maintaining quality and compliance. 

Key takeaways: 

• Explore how CDMOs contribute to innovation in CGT manufacturing 

• Identify strategies to optimize production processes and workflows 

• Assess approaches to scale manufacturing while maintaining quality and regulatory compliance 

• Discuss collaboration models between CDMOs, biotechs, and pharma 

• Evaluate opportunities for CDMOs to accelerate time-to-market for advanced therapies